The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or "the Company"), an oncology-focused drug development company, today announced a research grant awarded from The Michael J. Fox Foundation for ...

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. The company was founded by Graham Edmund Kelly in March 1994 ...

SYDNEY - Kazia Therapeutics Limited (NASDAQ: KZIA), a micro-cap biotech company with a market capitalization of $4.97 million specializing in oncology drug development, has received a research grant ...

SYDNEY - Kazia Therapeutics Limited (NASDAQ: KZIA), a micro-cap biotech company with a market capitalization of $4.97 million specializing in oncology drug development, has received a research ...

Kazia Therapeutics (KZIA) announced a research grant awarded from The Michael J. Fox Foundation for Parkinson’s Research, MJFF, to fund research between The Hebrew University of Jerusalem and ...

We recently compiled a list of the 10 Best Australian Stocks to Buy Now. In this article, we are going to take a look at where Kazia Therapeutics Limited (NASDAQ:KZIA) stands against other best ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...